Clinical Trials Directory

Trials / Completed

CompletedNCT07101224

Data Registry in Chinese Hemophilia A and B Patients

Data Registry in Chinese Hemophilia A and B Patients Related to the Use of Anti-hemophilic Coagulation Factor Replacement Therapy

Status
Completed
Phase
Study type
Observational
Enrollment
200 (actual)
Sponsor
Institute of Hematology & Blood Diseases Hospital, China · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

This is an open-label, prospective, multi-center, patient registry in Chinese Hemophilia A and B patients treated with anti-hemophilic coagulation factor replacement therapy.

Conditions

Timeline

Start date
2017-05-07
Primary completion
2019-06-30
Completion
2019-06-30
First posted
2025-08-03
Last updated
2025-08-03

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT07101224. Inclusion in this directory is not an endorsement.